Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Endoscopy
|
March 24, 2012
Factors influencing the miss rate of polyps in a back-to-back colonoscopy study
A M Leufkens, M G H van Oijen, F P Vleggaar, et al.
The Netherlands Journal of Medicine
|
June 8, 2011
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review
T J G Gevers, S Slavenburg, M G H van Oijen, et al.
Endoscopy
|
July 27, 2012
Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal
N L de Groot, J H Bosman, P D Siersema, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Perspectives, willingness, and current use of mobile health (mHealth) by patients with cancer for remote monitoring during cancer treatment: a Dutch national cross-sectional survey
D G Stuijt, M Kos, I Dingemans, et al.
Alimentary Pharmacology & Therapeutics
|
July 4, 2012
Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study
N L de Groot, J H Bosman, P D Siersema, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
November 22, 2007
The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease
M G H van Oijen, R J F Laheij, J B M J Jansen, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers
B M R Spiegel, M Farid, M G H van Oijen, et al.
Digestion
|
September 18, 2010
Microalbuminuria is not a valuable marker for relapse in Crohn's disease
C S Horjus, M G H van Oijen, A H Davids, et al.
ESMO Open
|
April 8, 2023
Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
H C Post, T Schutte, M G H van Oijen, et al.
Cancer Metastasis Reviews
|
August 13, 2015
Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis
N Haj Mohammad, E ter Veer, L Ngai, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Endoscopy
|
March 24, 2012
Factors influencing the miss rate of polyps in a back-to-back colonoscopy study
A M Leufkens, M G H van Oijen, F P Vleggaar, et al.
The Netherlands Journal of Medicine
|
June 8, 2011
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review
T J G Gevers, S Slavenburg, M G H van Oijen, et al.
Endoscopy
|
July 27, 2012
Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal
N L de Groot, J H Bosman, P D Siersema, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Perspectives, willingness, and current use of mobile health (mHealth) by patients with cancer for remote monitoring during cancer treatment: a Dutch national cross-sectional survey
D G Stuijt, M Kos, I Dingemans, et al.
Alimentary Pharmacology & Therapeutics
|
July 4, 2012
Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study
N L de Groot, J H Bosman, P D Siersema, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
November 22, 2007
The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease
M G H van Oijen, R J F Laheij, J B M J Jansen, et al.
Alimentary Pharmacology & Therapeutics
|
February 3, 2009
Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers
B M R Spiegel, M Farid, M G H van Oijen, et al.
Digestion
|
September 18, 2010
Microalbuminuria is not a valuable marker for relapse in Crohn's disease
C S Horjus, M G H van Oijen, A H Davids, et al.
ESMO Open
|
April 8, 2023
Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
H C Post, T Schutte, M G H van Oijen, et al.
Cancer Metastasis Reviews
|
August 13, 2015
Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis
N Haj Mohammad, E ter Veer, L Ngai, et al.
Page
of 6